Adriana Heindorfer
Liberec, LI, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Treatment Patterns and Outcomes in Over 2200 Newly Diagnosed Multiple Myeloma Patients: Supporting Bortezomib-Lenalidomide-Dexamethasone as a Preferred Regimen in the Absence of Anti-CD38 Antibodies.
Journal: Clinical lymphoma, myeloma & leukemia
Published: June 10, 2025
Several factors that predict the outcome of large B-cell lymphoma patients who relapse/progress after chimeric antigen receptor (CAR) T-cell therapy can be identified before cell administration.
Journal: Cancer medicine
Published: April 28, 2024
Clinical characteristics and outcomes in risk-stratified patients with smoldering multiple myeloma: data from the Czech Republic Registry of Monoclonal Gammopathies.
Journal: Blood cancer journal
Published: April 19, 2023
Bortezomib-based therapy for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation: Czech Registry Data.
Journal: European journal of haematology
Published: April 03, 2021
Urine immunofixation negativity is not necessary for complete response in intact immunoglobulin multiple myeloma: Retrospective real-world confirmation.
Journal: International journal of laboratory hematology
Published: August 17, 2020
Identification of patients with smouldering multiple myeloma at ultra-high risk of progression using serum parameters: the Czech Myeloma Group model.
Journal: British journal of haematology
Published: December 04, 2019
Validation of multiple myeloma risk stratification indices in routine clinical practice: Analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies.
Journal: Cancer medicine
Published: April 30, 2018
Simplified novel prognostic score for real-life older adults with multiple myeloma-registry-based analysis.
Journal: Annals of hematology
Published: April 09, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026